In this episode, Scott Becker discusses the sharp decline in Hims & Hers stock following the FDA’s announcement on the end of a weight loss drug shortage.
No transcript available.
In this episode, Scott Becker discusses the sharp decline in Hims & Hers stock following the FDA’s announcement on the end of a weight loss drug shortage.